Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT

Journal of Pharmaceutical Sciences

Volumn 101, Issue 1, 2012, Pages 116-126

  Kolhatkar, Vidula ^a   Diao, Lei ^a   Acharya, Chayan ^a   Mackerell, Alexander D ^a   Polli, James E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

ASBT; Bile acid; Inhibitor; Nonsteroidal; Prodrug; Substrate

Indexed keywords

BILE ACID CONJUGATE; HUMAN APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER MODEL; DNA FINGERPRINTING; HUMAN; KIDNEY CELL;

EID: 82255191710     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22728     Document Type: Article

References (24)

1. Dawson PA, Lan T, Rao A. 2009. Bile acid transporters. J Lipid Res 50(12):2340-2357.
2. Balakrishnan A, Polli JE. 2006. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): A potential prodrug target. Mol Pharm 3(3):223-230.
3. Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE. 2004. Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm 1(1):40-48.
4. Vallim TQ, Edwards PA. 2009. Bile acids have the gall to function as hormones. Cell Metab 10(3):162-164.
5. Knop FK. 2010. Bile-induced secretion of glucagon-like peptide-1: Pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 299(1):E10-E13.
6. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. 2010. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med 10(6):579-595.
7. Setchell KD, Rodrigues CM, Podda M, Crosignani A. 1996. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut 38(3):439-446.
8. Chang C, Swaan PW. 2006. Computational approaches to modeling drug transporters. Eur J Pharm Sci 27(5):411-424.
9. Swaan PW, Szoka FC Jr., Oie S. 1997. Molecular modeling of the intestinal bile acid carrier: A comparative molecular field analysis study. J Comput Aided Mol Des 11(6):581-588.
10. Baringhaus KH, Matter H, Stengelin S, Kramer W. 1999. Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)/bile acid cotransporter. J Lipid Res 40(12):2158-2168.
11. Rais R, Acharya C, Mackerell AD, Polli JE. 2010. Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates. Mol Pharm 7(6):2240-2254.
12. Zheng X, Pan Y, Acharya C, Swaan PW, Polli JE. 2010. Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid. Bioconjug Chem 21(11):2038-2048.
13. Brown RD, Martin YC. 1997. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J Chem Inf Comput Sci 37(1):1-9.
14. Butina D. 1999. Unsupervised data base clustering based on Daylight's fingerprint and Tanimoto similarity: A fast and automated way to cluster small and large data sets. J Chem Inf Comput Sci 39(4):747-750.
15. Xue L, Godden JW, Stahura FL, Bajorath J. 2003. Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme. J Chem Inf Comput Sci 43(4):1151-1157.
16. Balakrishnan A, Wring SA, Coop A, Polli JE. 2006. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. Mol Pharm 3(3):282-292.
17. Lack L. 1979. Properties and biological significance of the ileal bile salt transport system. Environ Health Perspect 33:79-89.
18. Balakrishnan A, Sussman DJ, Polli JE. 2005. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT). Pharm Res 22(8):1269-1280.
19. Gonzalez PM, Acharya C, Mackerell AD Jr., Polli JE. 2009. Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids. Pharm Res 26(7):1665-1678.
20. Balakrishnan A, Hussainzada N, Gonzalez P, Bermejo M, Swaan PW, Polli JE. 2007. Bias in estimation of transporter kinetic parameters from overexpression systems: Interplay of transporter expression level and substrate affinity. J Pharmacol Exp Ther 320(1):133-144.
21. Weinman SA, Carruth MW, Dawson PA. 1998. Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic. J Biol Chem 273(52):34691-34695.
22. Rais R, Gonzalez PM, Zheng X, Wring SA, Polli JE. 2008. Method to screen substrates of apical sodium-dependent bile acid transporter. AAPS J 10(4):596-605.
23. Balakrishnan A, Wring SA, Polli JE. 2006. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): Influence of steroidal hydroxylation pattern and C-24 conjugation. Pharm Res 23(7):1451-1459.
24. El Harchaoui K, Akdim F, Stroes ES, Trip MD, Kastelein JJ. 2008. Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins. Am J Cardiovasc Drugs 8(4):233-242.